Laimer Gregor, Verdonschot Koen H M, Kopf Lina, van der Lei Susan, Scharll Yannick, Hannink Gerjon, Jenniskens Sjoerd F M, Meijerink Martijn R, Bale Reto, Overduin Christiaan G
Department of Radiology, Interventional Oncology, Stereotaxy and Robotics, Medical University Innsbruck, Innsbruck, Austria.
Department of Medical Imaging, Radiology, Radboud University Medical Center, Nijmegen, Netherlands.
Eur Radiol. 2025 Feb;35(2):1046-1056. doi: 10.1007/s00330-024-10956-5. Epub 2024 Aug 2.
To assess the association between minimal ablative margin (MAM) and local tumor progression (LTP) following CT-guided thermal ablation of colorectal liver metastases (CRLM) in a multicenter cohort and across two confirmation software.
This multicenter retrospective study included patients who underwent CT-guided radiofrequency or microwave ablation for CRLM between 2009 and 2021 in three institutions. Three-dimensional (3D) MAM was retrospectively assessed using dedicated ablation confirmation software by automatic non-rigid (Ablation-fit) or semi-automatic rigid co-registration (SAFIR) of intraprocedural pre- and post-ablation contrast-enhanced CT scans by two independent reader teams blinded to patient outcomes. LTP was assessed on a per-tumor basis. Factors associated with LTP-free survival were assessed using multivariable Cox regression analysis.
Overall, 113 patients (mean age: 67 ± 10 years; 78 men) who underwent thermal ablation for 189 CRLM (mean diameter: 1.9 ± 1.1 cm) met the inclusion criteria. 173/189 (92%) CRLM could be successfully analyzed using both software. Over a median follow-up of 31 months (IQR: 22-47), 21 of 173 CRLM (12.1%) developed LTP. On multivariable analysis, 3D MAM was independently associated with LTP in both software (Ablation-fit: HR 0.47, 95% CI: 0.36-0.61, p < 0.001; SAFIR: HR 0.42, 95% CI: 0.32-0.55, p < 0.001). No LTP was observed in CRLM ablated with MAM ≥ 4 mm (Ablation-fit) and ≥ 5 mm (SAFIR). The per-tumor median absolute difference in MAM quantification between both software was 2 mm (IQR: 1-3).
MAM was independently associated with LTP after thermal ablation of CRLM across multicenter data and two confirmation software. Ablations achieving a MAM ≥ 5 mm were associated with local control in both software.
MAMs from intraprocedural contrast-enhanced CT were independently associated with LTP after thermal ablation of CRLM across multicenter data and two confirmation software, with a margin ≥ 5 mm associated with local control in both software.
Sufficient ablative margins are critical for local control following thermal ablation of CRLM. Intraprocedural CT-derived MAM was the only independent factor associated with LTP across two confirmation software. No LTP was observed in CRLM ablated with a MAM ≥ 5 mm.
在一个多中心队列中,通过两种确认软件评估CT引导下热消融结直肠癌肝转移瘤(CRLM)后最小消融边缘(MAM)与局部肿瘤进展(LTP)之间的关联。
这项多中心回顾性研究纳入了2009年至2021年期间在三个机构接受CT引导下射频或微波消融CRLM的患者。通过专用消融确认软件,由两个对患者预后不知情的独立阅片团队,对术中消融前后的对比增强CT扫描进行自动非刚性(Ablation-fit)或半自动刚性配准(SAFIR),回顾性评估三维(3D)MAM。基于每个肿瘤评估LTP。使用多变量Cox回归分析评估与无LTP生存相关的因素。
总体而言,113例患者(平均年龄:67±10岁;78例男性)因189个CRLM(平均直径:1.9±1.1cm)接受热消融,符合纳入标准。173/189(92%)个CRLM可使用两种软件成功分析。在中位随访31个月(IQR:22 - 47)期间,173个CRLM中有21个(12.1%)发生LTP。多变量分析显示,在两种软件中3D MAM均与LTP独立相关(Ablation-fit:HR 0.47,95%CI:0.36 - 0.61,p < 0.001;SAFIR:HR 0.42,95%CI:0.32 - 0.55,p < 0.001)。MAM≥4mm(Ablation-fit)和≥5mm(SAFIR)消融的CRLM未观察到LTP。两种软件之间MAM定量的每个肿瘤中位绝对差异为2mm(IQR:1 - 3)。
在多中心数据和两种确认软件中,MAM与CRLM热消融后的LTP独立相关。两种软件中,达到MAM≥5mm的消融与局部控制相关。
术中对比增强CT的MAM在多中心数据和两种确认软件中与CRLM热消融后的LTP独立相关,两种软件中边缘≥5mm与局部控制相关。
足够的消融边缘对CRLM热消融后的局部控制至关重要。术中CT衍生的MAM是两种确认软件中与LTP相关的唯一独立因素。MAM≥5mm消融的CRLM未观察到LTP。